Aprogen Medicines Market Cap

Aprogen Medicines has a market cap or net worth of 195.50 billion as of October 15, 2025. Its market cap has decreased by -49.26% in one year.

Market Cap

195.50B

Enterprise Value

633.16B

Revenue

127.33B

Ranking

n/a

PE Ratio

n/a

Stock Price

632.00

Market Cap Chart

Since December 7, 1995, Aprogen Medicines's market cap has increased from 19.56B to 195.50B, an increase of 899.50%. That is a compound annual growth rate of 8.01%.

Market Cap History

Date	Market Cap	% Change
Oct 15, 2025	195.50B	-11.09%
Dec 30, 2024	219.89B	-6.16%
Dec 28, 2023	234.32B	-41.38%
Dec 27, 2022	399.71B	19.11%
Dec 30, 2021	335.57B	-10.30%
Dec 30, 2020	374.12B	-10.38%
Dec 30, 2019	Upgrade Pro	Upgrade Pro
Dec 28, 2018	Upgrade Pro	Upgrade Pro
Dec 28, 2017	Upgrade Pro	Upgrade Pro
Dec 29, 2016	Upgrade Pro	Upgrade Pro
Dec 30, 2015	Upgrade Pro	Upgrade Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
LG Energy Solution	84.12T
Hanwha Aerospace	53.61T
Doosan Enerbility	47.71T
HD Hyundai Heavy Industries	45.72T
Hanwha Ocean	33.49T
Samsung C&T	33.03T
HD Korea Shipbuilding & Offshore Engineering	29.35T
Hyundai Rotem Company	24.01T

Market Cap Rankings